Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Landmann

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|October 15, 1990
[Possibilities for increasing the elimination rate of Bonnecor]C Fleck, L Schilder, U Schulze, et al.
Die Pharmazie|March 1, 1986
[Cardiac effects of Cordemcura in vitro]A Hagen, F Sonnenburg, B Frömmel, et al.
Bulletin of the International Union Against Tuberculosis and Lung Disease|June 1, 1988
Second IUATLD study on complications induced by intradermal BCG-vaccinationA Lotte, O Wasz-Hockert, N Poisson, et al.
Cell Death & Disease|September 12, 2014
UDP glucuronosyltransferase 1A expression levels determine the response of colorectal cancer cells to the heat shock protein 90 inhibitor ganetespibH Landmann, D A Proia, S He, et al.
Cancer Discovery|July 9, 2024
Rational Protein Engineering to Enhance MHC-Independent T-cell ReceptorsJu-Fang Chang, Jack H Landmann, Tien-Ching Chang, et al.
Cancer Immunology Research|June 13, 2024
Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen ReceptorsJu-Fang Chang, Nils Wellhausen, Nils W Engel, et al.
Nature Communications|June 11, 2022
Antigen glycosylation regulates efficacy of CAR T cells targeting CD19Amanda Heard, Jack H Landmann, Ava R Hansen, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Costimulatory domains direct distinct fates of CAR-driven T cell dysfunctionMehmet Emrah Selli, Jack H Landmann, Marina Terekhova, et al.
Blood|May 2, 2023
Costimulatory domains direct distinct fates of CAR-driven T-cell dysfunctionMehmet Emrah Selli, Jack H Landmann, Marina Terekhova, et al.
Blood Advances|July 20, 2022
Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapiesArmin Ghobadi, Jack H Landmann, Alun Carter, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|October 15, 1990
[Possibilities for increasing the elimination rate of Bonnecor]C Fleck, L Schilder, U Schulze, et al.
Die Pharmazie|March 1, 1986
[Cardiac effects of Cordemcura in vitro]A Hagen, F Sonnenburg, B Frömmel, et al.
Bulletin of the International Union Against Tuberculosis and Lung Disease|June 1, 1988
Second IUATLD study on complications induced by intradermal BCG-vaccinationA Lotte, O Wasz-Hockert, N Poisson, et al.
Cell Death & Disease|September 12, 2014
UDP glucuronosyltransferase 1A expression levels determine the response of colorectal cancer cells to the heat shock protein 90 inhibitor ganetespibH Landmann, D A Proia, S He, et al.
Cancer Discovery|July 9, 2024
Rational Protein Engineering to Enhance MHC-Independent T-cell ReceptorsJu-Fang Chang, Jack H Landmann, Tien-Ching Chang, et al.
Cancer Immunology Research|June 13, 2024
Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen ReceptorsJu-Fang Chang, Nils Wellhausen, Nils W Engel, et al.
Nature Communications|June 11, 2022
Antigen glycosylation regulates efficacy of CAR T cells targeting CD19Amanda Heard, Jack H Landmann, Ava R Hansen, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Costimulatory domains direct distinct fates of CAR-driven T cell dysfunctionMehmet Emrah Selli, Jack H Landmann, Marina Terekhova, et al.
Blood|May 2, 2023
Costimulatory domains direct distinct fates of CAR-driven T-cell dysfunctionMehmet Emrah Selli, Jack H Landmann, Marina Terekhova, et al.
Blood Advances|July 20, 2022
Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapiesArmin Ghobadi, Jack H Landmann, Alun Carter, et al.
Pageof 6